肺癌

肺癌是目前导致男性和女性相关癌症死亡的主要原因。尽管男性继续下降,但女性的发病率仍然稳定。肺癌相关死亡趋势反映了过去几十年吸烟的趋势。1 2021年,美国癌症协会估计将有235,760例新病例被诊断出来,美国将有131,880例因肺癌和支气管癌死亡发生。2

观看与Edward Levitt的完整采访, 一位肺癌的幸存者以及 The Lung Cancer Alliance of Georgia(乔治亚癌症联盟)的创始人。

以下是本节中能找到的信息列表

来自CQ的互动游戏

观看肺癌研究员Gerold Belpler博士的全面访谈

了解更多关于肺癌的信息或在Winship Cancer Institute of Emory University(埃默里大学Winship癌症研究所)预约。

  • 1. Alberg AJ, Brock MV, Samet JM. "Epidemiology of lung cancer: looking to the future." Journal of Clinical Oncology (2005): 23(14):3175-85 [PUBMED]
  • 2. American Cancer Society.Cancer Facts & Figures 2023. Atlanta: American Cancer Society. (2023). 取读于 从 https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html
  • 3.a. b. c. d. e. What is non-small cell lung cancer? American Cancer Society (Accessed October 2010). [http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/OverviewGuide/lung-cancer--non-small-cell--overview-non-small-cell-lung-cancer]
  • 4.a. b. c. d. Cancer Facts and Figures 2013. American Cancer Society. [http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf]
  • 5.a. b. c. Jackman DM, Johnson BE. "Small-cell lung cancer." Lancet (2005); 366(99494):1385-96 [PUBMED]
  • 6. Yang P, Bamlet WR, Ebbert JO, Taylor WR, de Andrade M. "Glutathione pathway genes and lung cancer risk in young and old populations." Carcinogenesis (2004); 25(10):1935-44 [PUBMED]
  • 7. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. "Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers." Oncogene (2002); 21(48):7435-51 [PUBMED]
  • 8. The Health Consequences of Smoking: A Report of the Surgeon General. United States Department of Health & Human Services. May 27, 2004. [http://www.surgeongeneral.gov/library/smokingconsequences/]
  • 9. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. United States Department of Health & Human Services. June 27, 2006. [http://www.surgeongeneral.gov/library/secondhandsmoke/report/]
  • 10. Zielinski JM, Carr Z, Krewski D, Repacholi M. "World Health Organization's International Radon Project." Journal of Toxicology and Environmental Health, Part A (2006); 69(7):759-69 [PUBMED]
  • 11. Alavanja MC. "Biologic damage resulting from exposure to tobacco smoke and from radon: implication for preventative interventions." Oncogene (2002); 21(48):7365-75 [PUBMED]
  • 12. Nelson HH, Kelsey KT. "The molecular epidemiology of asbestos and tobacco in lung cancer." Oncogene (2002); 21(48):7284-8 [PUBMED]
  • 13.a. b. Littman AJ, Thornquist MD, White E, Jackson LA, Goodman GE, Vaughan TL. "Prior lung disease and risk of lung cancer in a large prospective study." Cancer Causes and Control (2004); 15(8):819-27 [PUBMED]
  • 14. Ganti AK, Mulshine JL. "Lung Cancer Screening." The Oncologist (2006); 11(5):481-7 [PUBMED]
  • 15. Humphrey LL, Johnson M, Teutsch S. Lung Cancer Screening: An Update for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004 May. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. [PUBMED]
  • 16. Can non-small cell lung cancer be found early? American Cancer Society. (Accessed October 2010) [http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-detection]
  • 17.a. b. c. d. e. Toloza EM, Morse MA, Lyerly HK. "Gene therapy for lung cancer." Journal of Cellular Biochemistry (June 9, 2006); [epub ahead of print] [PUBMED]
  • 18. Dowell JE. "Epidermal growth factor receptor mutations in non-small cell lung cancer: a basic science discovery with immediate clinical impact." American Journal of the Medical Sciences (2006); 331(3):139-49 [PUBMED]
  • 19. Fish-Steagall A, Searcy P, Sipples R. "Clinical experience with anti-EGFR therapy." Seminars in Oncology Nursing (2006); 22(1 Suppl 1):10-9 [PUBMED]